Clinical Trials Directory

Trials / Completed

CompletedNCT02987985

Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy

Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy: a Pilot Study

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
50 (actual)
Sponsor
University of Saskatchewan · Academic / Other
Sex
All
Age
12 Years
Healthy volunteers
Not accepted

Summary

The objective of this trial is to determine whether an opioid-free general anesthetic (OFA) technique utilizing ketamine, dexmedetomidine, lidocaine, and gabapentin can help reduce postoperative respiratory depression in the post-anesthesia care unit and ward in children with sleep-disordered breathing undergoing tonsillectomy when compared with traditional opioid-containing techniques. It is expected that this OFA regimen will have a measurable reduction on postoperative respiratory depression in children with sleep-disordered breathing.

Detailed description

The objective of this trial is to determine whether an opioid-free general anesthetic can help reduce postoperative respiratory depression in the post-anesthesia care unit and ward in children with sleep-disordered breathing undergoing tonsillectomy when compared with traditional opioid-containing techniques.

Conditions

Interventions

TypeNameDescription
DRUGAcetaminophen, gabapentinacetaminophen 15 mg/kg, gabapentin 10 mg/kg
DRUGAcetaminophenacetaminophen 15 mg/kg
DRUGKetamine , Lidocaine , DexmedetomidineKetamine 0.5 mg/kg, Lidocaine 1 mg/kg, Dexmedetomidine 0.3 mcg/kg
DRUGFentanyl, DexmedetomidineFentanyl 0.5 mcg/kg, Dexmedetomidine 0.3 mcg/kg
DRUGDexamethasone , OndansetronDexamethasone 150 mcg/kg, Ondansetron 50 mg/kg
DRUGSevofluraneSevoflurane (dose titrated to effect)
DRUGSevoflurane, FentanylSevoflurane (dose titrated to effect), Fentanyl as needed (dose at anesthesiologist's discretion)

Timeline

Start date
2017-10-15
Primary completion
2019-09-20
Completion
2020-12-20
First posted
2016-12-09
Last updated
2021-08-10

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02987985. Inclusion in this directory is not an endorsement.